Comparative Cost-Effectiveness Analysis of Avelumab plus Axitinib Versus Pembrolizumab plus Axitinib, Ipilimumab plus Nivolumab, and Sunitnib for Advanced Renal Cell Carcinoma in the Uk Perspective

AuthID
 P-00S-4K6
8
Author(s)
Ayoub, E
·
Castelo Branco, P
·
De Almeida Zia, VAD
·
Savio, A
·
Tadokoro, H
·
Teich, N
Document Type
Abstract
Year published
2020
Published
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 38, Issue: 6
Conference
Genitourinary Cancers Symposium of the American-Society-Of-Clinical-Oncology (Asco), Date: FEB 13-15, 2020, Location: San Francisco, CA, Sponsors: Amer Soc Clin Oncol
Indexing
Wos®
Publication Identifiers
Wos: WOS:000529525900692
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service